Comparison of DCT, ORA & GAT in Eyes After Penetrating Keratoplasty

Status Unknown status

Clinical Trial Summary

To compare intraocular pressure (IOP) measured by the Reichert Ocular Response Analyzer (ORA), Pascal dynamic contour tonometer (DCT) and Goldmann applanation tonometer (GAT) in eyes after Penetrating Keratoplasty (KPL)

Clinical Trial Description

A few tonometers are used today in clinical practice for measuring intra ocular pressure (IOP). Each tonometer is based on different technology.

Post penetrating keratoplasty (PK) eyes are at risk for developing secondary glaucoma (9-14%). Elevation of the IOP may cause rejection of the graft or alternately a loss in the endothelial cell layer count causing decompensation of the cornea. Therefore, measuring accurately the IOP in this population is of great importance.

Measuring IOP in post PK is not an easy challenge, mainly because of parameters like the central corneal thickness (CCT), the curvature of the cornea, the axial length and biomechanical properties which diverse from normal eyes.

The Goldmann applanation tonometer (GAT) is the gold standard tonometer for measuring IOP and is the most popular tonometer clinically used. IOP measurements via the GAT are based on the assumption that the CCT is constant. post PK eyes CCT might diverse from normal eyes causing GAT IOP measurements to be inaccurate. The Pascal dynamic contour tonometer (DCT) measures IOP independently of corneal parameters. The Ocular response analyzer (ORA) is based on a non contact technique of measurement. The tonometer is thought to be independent of factors such as CCT.

The aim of the study is to compare intraocular pressure (IOP) measured by the Reichert Ocular Response Analyzer (ORA), Pascal dynamic contour tonometer (DCT) and Goldmann applanation tonometer (GAT) in eyes after Penetrating Keratoplasty (KPL). In addition its aim is to discover the dependence of different parameters, like - CCT, curvature of the cornea, axial length and biomechanical properties on IOP measurement to elucidate the appropriate tonometer for this population. ;

Study Design

Related Conditions & MeSH terms

Corneal Transplantation

Clinical Trial Details

NCT number	NCT00834782
Study type	Observational
Source	Sheba Medical Center
Contact	Ido Didi Fabian, Dr
Phone	+9727830444
Email	didifabian@gmail.com
Status	Unknown status
Phase	Phase 4
Start date	May 2009
Completion date	May 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01206127` - DSAEK- Postoperative Positioning and Transplant Dislocation	N/A
Terminated	`NCT00764582` - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery	Phase 4
Recruiting	`NCT05870566` - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]	N/A
Recruiting	`NCT02084745` - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis	N/A
Withdrawn	`NCT00345020` - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed	`NCT00000137` - Collaborative Corneal Transplantation Studies (CCTS)	Phase 3
Recruiting	`NCT04339907` - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)	N/A
Active, not recruiting	`NCT00874835` - Corneal Endothelium Delivery Instrument	Phase 2
Completed	`NCT00570648` - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization	N/A
Enrolling by invitation	`NCT03461978` - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures	N/A
Not yet recruiting	`NCT05210478` - Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
Completed	`NCT01694914` - Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium	Phase 3
Completed	`NCT03381794` - The German Keratoplasty Registry of the German Ophthalmological Society (DOG)	N/A
Recruiting	`NCT03105466` - Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea	N/A
Completed	`NCT00409656` - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients	Phase 2
Recruiting	`NCT01018888` - Safety and Efficacy Study of Artificial Cornea	Phase 4
Recruiting	`NCT04490902` - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty	N/A
Recruiting	`NCT04337944` - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)	N/A
Completed	`NCT01547975` - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation	N/A
Terminated	`NCT00447642` - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms